Regulations Amending the Narcotic Control Regulations (Synthetic Opioids): SOR/2024-99

Canada Gazette, Part II, Volume 158, Number 12

Registration
SOR/2024-99 May 27, 2024

CONTROLLED DRUGS AND SUBSTANCES ACT

P.C. 2024-575 May 24, 2024

Her Excellency the Governor General in Council, on the recommendation of the Minister of Mental Health and Addictions and Associate Minister of Health, makes the annexed Regulations Amending the Narcotic Control Regulations (Synthetic Opioids) under subsection 55(1)^{footnote a} of the Controlled Drugs and Substances Act ^{footnote b}.

Regulations Amending the Narcotic Control Regulations (Synthetic Opioids)

Amendment

1 The schedule to the Narcotic Control Regulations ^{footnote 1} is amended by adding the following after item 19:

• 20AP-237 (1-(4-cinnamylpiperazin-1-yl)butan-1-one), its salts, derivatives and analogues and salts of derivatives and analogues, including:
  • (1)2-methyl-AP-237 (1-(4-cinnamyl-2-methylpiperazin-1-yl)butan-1-one)
  • (2)para-methyl-AP-237 ((E)-1-(4-(3-(p-tolyl)allyl)piperazin-1-yl)butan-1-one)
  • (3)AP-238 (1-(4-cinnamyl-2,6-dimethylpipe-razin-1-yl)propan-1-one)

Coming into Force

2 These Regulations come into force on the day on which they are published in the Canada Gazette, Part II.

N.B. The Regulatory Impact Analysis Statement for these Regulations appears following SOR/2024-98, Order Amending Schedules I and VI to the Controlled Drugs and Substances Act (Synthetic Opioids and Emerging Fentanyl Precursors).